Park Square Financial Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2058285 ROSWELL, GA

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$6,064

-$4,468 QoQ

Shares Held

-49.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#2,212

of 2,266 holders

Holding Since

Jun 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Park Square Financial Group, LLC holds $191,148 across 6 Drug Manufacturers - General names. GILD ranks #5 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	120	$143,930
2	JNJ	Johnson & Johnson	81	$20,571
3	MRK	Merck & Co., Inc.	76	$9,766
4	AZN	Astrazeneca PLC	43	$8,153
5	GILD	Gilead Sciences, Inc. This page	48	$6,064
6	NVS	Novartis AG	17	$2,664

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,064	48	-49.5%	Shares	Sole	2026-07-31
2025-06-30	$10,532	95	—	Shares	Sole	2025-08-12
No filing history on record for this holder in this stock.